The largest database of trusted experimental protocols

29 protocols using tnf α

1

Evaluating Connexin Mimetic Peptides in Cell Cultures

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEPES, water (W3500), Dulbecco′s Modified Eagle Medium (DMEM), 4,6,-O-ethylidene-D-glucose (ETDG), anti-GFAP polyclonal antibody, cytosine arabinoside (Ara-C), LaCl3 (La3+), cytochalasin B (Cyto-B) and ethidium (Etd) bromide were purchased from Sigma-Aldrich (St. Louis, MO, USA). Fetal bovine serum (FBS) was purchased from Hyclone (Logan, UT, USA), whereas penicillin, 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose (2-NBDG), streptomycin, Propidium (Prd) iodide, diamidino-2-phenylindole (DAPI), YO-PRO-1, goat anti-mouse Alexa Fluor 488/555 and goat anti-rabbit Alexa Fluor 488/555 were from Thermo Fisher Scientific (Waltham, MA, USA). IL-1β and TNF-α were obtained from Roche Diagnostics (Indianapolis, MI, USA). Normal goat serum (NGS) was purchased from Zymed (San Francisco, CA, USA). Anti-Cx43 monoclonal antibody (610061) was obtained from BD Biosciences (Franklin Lakes, NJ, USA). The mimetic peptides gap19 (KQIEIKKFK, intracellular loop domain of Cx43), gap19I130A (KQAEIKKFK, negative control), Tat-L2 (YGRKKRRQRRR-DGANVDMHLKQIEIKKFKYGIEEHGK, intracellular loop domain of Cx43), and Tat-L2H126K/I130N (YGRKKRRQRRR-DGANVDMKLKQNEIKKFKYGIEEHGK, negative control) were obtained from Genscript (Piscataway, NJ, USA).
+ Open protocol
+ Expand
2

Cytokine-Mediated Signaling Pathway Regulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cytokines TGF-β1, TNF-α and IL-6 (Roche Diagnostics; Indianapolis, IN, USA) were added at 0.1, 1, or 10 ng/ml to cancer cells in serum-free DMEM and incubated at 37°C in an atmosphere of 5% CO2 for 48 h or as indicated. Smad3 inhibitor (SIS3; Merck KGaA, Billerica, MA, USA; 1, 5 or 10 µM), 100 µM pyrrolidine dithiocarbamate (PDTC; Sigma-Aldrich; Merck KGaA, Darmstadt, Germany), 1 µM wortmannin (Sigma-Aldrich; Merck KGaA), 10 µM SP600125 (Sigma-Aldrich; Merck KGaA), 10 µM U0126 (Sigma-Aldrich; Merck KGaA) or 10 µM SB202190 (Merck KGaA) were incubated with confluent HeLa cells for 1 h at 37°C in a 5% CO2 atmosphere. A total of 10 ng/ml TGF-β1 was then added and the cells were incubated for an additional 48 h.
+ Open protocol
+ Expand
3

Culturing and Treating Human Cortical Neurons

Check if the same lab product or an alternative is used in the 5 most similar protocols
We purchased HCN-1A, primary human cortical neuronal cells, from American Type Culture Collection (ATCC, Manassas, VA). Dulbecco’s modified Eagle’s medium (DMEM, ATCC) supplemented with 20 % bovine calf serum, 1 % antibiotic–antimycotic, and 1 % l-glutamine (Life Technologies, Grand Island, NY) was used to culture HCN-1A cells according to the ATCC recommendations. The HCN-1A cells were used in immunohistochemistry. During the course of our studies, ATCC discontinued the distribution of HCN-1A cells due to quick senescence of the cells and insufficient inventory. The HCN-1A cells were thus unavailable for use in other assays. HCN-1A cells were treated overnight (17 h) with either the 40 amino acid Aβ peptide (Aβ1−40, Bachem, Torrance, CA, stock solution in ultrapure water) at a concentration of 125 µg/ml or human recombinant tumor necrosis factor-alpha (TNF-α, Roche, Indianapolis, IN) at a concentration of 25 ng/ml. Control treatments included HCN-1A incubation with either inactive (reverse peptide order) Aβ peptide (Aβ40−1) (Bachem, stock solution in 10 % acetic acid) or vehicle alone (basal medium or basal medium containing an equivalent volume of 10 % acetic acid). Aβ was diluted in basal medium and incubated for 2 h at room temperature before administration, to allow the formation of toxic oligomers and fibrillar aggregates that are found in AD.
+ Open protocol
+ Expand
4

Selective Liver Irradiation Mouse Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
All mice used in this study were male and 8‐12 weeks old with a body weight of 20‐28 g. Mice were purchased from The Jackson Laboratory (Bar Harbor, ME, USA). Wild‐type (wt) (C57BL/6J) mice received single‐dose selective liver irradiation (25 Gy, dose rate 2.4 Gy/min) with or w/o injection of TNF‐α (2 μg/mouse) (Roche, Penzberg, Germany). A single injection of TNF‐α was administered intraperitoneally (i.p.) 20 minutes before irradiation, as described previously.27 PECAM‐1‐knock‐out (ko) (B6.129S‐Pecam1Gt(OST16303)Lex/J) mice also received selective liver irradiation with a single dose of 25 Gy as described before.4 The animals were killed at regular intervals at 1‐48 hours after irradiation. Sham‐irradiated and PBS‐injected (i.p.) control animals (n = 3 per each time‐point) were studied simultaneously in all experiments.
All animal studies were reviewed and approved by the committee of the Central Institute for Animal Experiments of the University Medical Centre Goettingen, and the Lower Saxony State Office for Consumer Protection and Food Safety (No. 33.12‐42502‐04‐10/0158).
+ Open protocol
+ Expand
5

Neonatal Rat Ventricular CMs: TNF-α Exposure

Check if the same lab product or an alternative is used in the 5 most similar protocols
Neonatal rat ventricular CMs were harvested and prepared from 1 day postnatal Sprague-Dawley rats as previously described 14 (link). Details are provided in Supplementary Methods. TNF-α treatment was performed by adding TNF-α Sigma Aldrich) to a final concentration of 25 ng/mL for 24 hours. Cells were harvested by mechanical scraping followed by RNA or protein extraction. Alternatively, an apoptosis assay was performed on TNF-α treated cells using the cell death detection ELISAPLUS kit (Roche) according to manufacturer’s protocol.
+ Open protocol
+ Expand
6

Cytokine-induced Inflammation in ARPE-19 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
ARPE-19 human RPE cells obtained from ATCC (Manassas, VA) were grown to confluence as we reported earlier [8 (link), 9 (link)]. The cells were treated with the proinflammatory cytokines IFN-γ (10 u/ml), IL-1β (1 ng/ml) and TNF-α (1 ng/ml) in the absence of serum for 16 h unless otherwise indicated. The cells were pre-incubated with Resveratrol (50 μM) for 4 hours also in the absence of serum prior to the cytokine treatment when required. Resveratrol was obtained from Sigma-Aldrich, St. Louis, MO and dissolved in ethanol before adding to cell culture medium. Equal volume of ethanol was added to controls. Human IL-1β was purchased from R&D Systems, Minneapolis, MN while TNF-α and IFN-γ were from Roche Applied Science, Indianapolis, IN.
+ Open protocol
+ Expand
7

NF-κB Activation Dynamics in HEK293 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK293 cells were plated in 24-well plates (Cell-Bind from Corning) and transfected with 50, 100, or 150 ng of pcDNA3.1 – PLpro plasmid, 50 ng pNFkB-luc, and 25 ng pRL-TK (Renilla control) per well in triplicate (Mirus LT-1). Cells were incubated for 12 hours, media removed, and fresh media containing TNFα (Roche) at a final concentration of 10 ng/ml was added and incubated with cells for 4 hours. Cells were then lysed with passive lysis buffer and wells assayed for dual luciferase expression (Promega) by luminometer. p<.05 indicates a significant difference from mock transfected cells and was determined using a student t test with Systat.
+ Open protocol
+ Expand
8

Profiling ECTV and VACV Induced NF-κB Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
HeLa cells or MEF cells were mock-infected or infected with ECTV, VACV, or ECTV-Δ005 at a MOI of 5 for 12 hours followed by stimulation with either 10 ng/ml TNFα (Roche) or 10 ng/ml IL-1β (PeproTech Inc) for 20 minutes. Cells were harvested and lysed in cytoplasmic extract buffer containing 10 mM HEPES, 10 mM KCl, 0.1 mM EDTA (pH 8.0), 0.1 mM EGTA (pH 8.0), 1 mM dithiolthreitol (DTT) and 0.05% NP40. Samples were centrifuged at 1000× g for five minutes to remove nuclei. Supernatants were collected and resuspended in SDS sample buffer. The nuclear pellets were washed and resuspended in nuclear extract buffer containing 20 mM HEPES, 25% glycerol, 0.4M NaCl, 1 mM EDTA (pH 8.0), 1 mM EGTA (pH 8.0), and 1 mM DTT and lysis was performed on ice for 30 minutes. Samples were centrifuged at 1000× g for five minutes. Supernatants were collected as nuclear extracts and mixed with SDS sample buffer.
+ Open protocol
+ Expand
9

Quantification of IκBα Degradation

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK293 cells were plated in 60 mm dishes and transfected with 3 ug pcDNA3.1 – PLpro and 250 ng pIkBα-HA per dish (Mirus LT-1) [42] (link). Cells were incubated for 24 hours, media, removed, and fresh media containing TNFα (Roche) at a final concentration of 20 ng/ml was added and incubated with cells. Cells were incubated with TNFα for the indicated time points. Cells were then lysed with an IkBα lysis buffer: 20 mM Tris (pH 7.5), 150 mM NaCl, 1 mM EGTA, 1 mM EDTA, 1% Triton X-100, 2.5 mM Na pyro-phosphate, 1 mM Beta-glycerophosphate, 1 mM Na ortho-vanadate, 1 ug/ml Leupeptin. Lysates were kept on ice and centrifuged at 14000× g for 10 min at 4C. After centrifugation, supernatant was added to equal volume 2× sample buffer, boiled for 5 min, and then immediately run on 10% SDS-PAGE gel. Gel was transferred to PVDF using a semi-dry blot apparatus (TransBlot Turbo, Bio-Rad) and blocked in 5% milk overnight. Antibodies were used at a concentration of 1∶5000 (mαHA, Covance; mαV5, Invitrogen). Western blots were quantified using a Typhoon Image Scanner and ImageQuant5. p<.05 indicates a significant difference from WT PLpro transfected cells and was determined using a student t test with Systat.
+ Open protocol
+ Expand
10

Endothelial Cell Response to Shiga Toxin

Check if the same lab product or an alternative is used in the 5 most similar protocols
The experiments were performed using human endothelial cells obtained from adult renal tissue that were removed due to medical reasons or isolated from human umbilical veins. The described studies were approved by the appropriate ethics committee and were therefore performed in accordance with the ethical standards laid down in the appropriate version of the 1964 Declaration of Helsinki. All donors gave their informed consent prior to inclusion in this study.
Primary HGMVECs were obtained from human kidneys of three donors and cultured as described previously [38 (link)]; passages 8–10 were used for experiments. HUVECs from three donors were harvested according to a previously described method [39 (link)], and passages 3–4 were used for experiments. Confluent cells were stimulated for 6, 12, 24, and 48 h with Stx1 (0.0, 0.1, and 1.0 nM) with or without 24 h preincubation with 10 ng/mL of TNFα (Roche Diagnostics). Stx1 was a kind gift from M. Bielaszewska (University of Münster, Münster, Germany) and was endotoxin-free, as determined by a Limulus assay.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!